"If the survival after 4 years is nearly double the next best thing"
If it were true, that would be the case. But the evidence so far only qualifies as "anecdotal".
So it needs to be proven in a randomized controlled blinded clinical trial.
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-232
-
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.005(0.42%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.18 | $313.3K | 265.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21092 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 4650 | 1 |
View Market Depth
| Last trade - 10.06am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |